v3.25.4
Stockholders' Equity - SAR and Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Options Outstanding Number of Shares      
Outstanding as of beginning of period (in shares) 7,198    
Granted (in shares) 484    
Exercised (in shares) (1,606)    
Canceled and forfeited (in shares) (208)    
Outstanding as of end of period (in shares) 5,868 7,198  
Exercisable (in shares) 2,160    
Weighted-Average Exercise Price Per Share      
Outstanding as of beginning of period (in dollars per share) $ 40.16    
Granted (in dollars per share) 74.44    
Exercised (in dollars per share) 18.73    
Canceled and forfeited (in dollars per share) 46.59    
Outstanding as of end of period (in dollars per share) 48.72 $ 40.16  
Exercisable (in dollars per share) $ 27.68    
Additional Disclosures      
Weighted-Average Remaining Contractual Life (in years), Outstanding 4 years 9 months 14 days 4 years 10 months 24 days  
Weighted-Average Remaining Contractual Life (in years), Exercisable 3 years 2 months 1 day    
Aggregate Intrinsic Value, Outstanding $ 194 $ 153  
Intrinsic value of options exercised during period 0 $ 433 $ 319
Aggregate Intrinsic Value, Exercisable $ 118    
SARs      
SARs Outstanding Number of SARs      
Outstanding as of beginning of period (in shares) 33    
Granted (in shares) 0    
Exercised (in shares) (14)    
Canceled and forfeited (in shares) (3)    
Outstanding as of end of period (in shares) 16 33  
Exercisable (in shares) 16